S

Spyryx Biosciences

50 employees

Spyryx Biosciences develops a next-generation therapeutics for obstructive lung diseases.

Basic info

Industry

biotechnology research

Sectors

Respiratory Therapeutics
Biotechnology
Health Diagnostics
Health Care
Cystic Fibrosis
Therapeutics
Genetics
Rare and Orphan Diseases
Pulmonary

Date founded

2013

Funding rounds raised

Total raised

$18M

from 2 investors over 2 rounds

S

Spyryx Biosciences raised $18M on May 7, 2015

Investors: 5AM Ventures and Canaan

FAQ